Sabby Management’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
Other funds holding ZVRA
Sabby Management's ZVRA Position: Q3 2026 in Review
Sabby Management opened a new position in Zevra Therapeutics (ZVRA) in Q3 2026: 57,850 shares worth $635K. The stake represents 7.04% of the portfolio and ranks #5 among its holdings. This is a return to the name: Sabby Management previously reported a position in ZVRA as recently as Q4 2022.
Sabby Management first reported a position in ZVRA in Q2 2021 and has held it in 8 quarters since. The position peaked at $2.21M in Q2 2021. 174 funds tracked by Wall St. Rank hold ZVRA as of Q3 2026.
- Sabby Management held 57,850 shares of Zevra Therapeutics worth $635K as of Q3 2026.
- Zevra Therapeutics was a new Sabby Management position in Q3 2026.
- Zevra Therapeutics made up 7.04% of Sabby Management's portfolio in Q3 2026, its #5 holding.
- Sabby Management first reported a position in Zevra Therapeutics in Q2 2021 and has held it in 8 quarters since.
- Sabby Management's Zevra Therapeutics position peaked at $2.21M in Q2 2021.
- 174 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2026.
Based on Sabby Management's 13F filing for Q3 2026, filed 13 Nov 2026.